Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current concepts in acute leukemia.

K B McCredie

    Postgraduate Medicine
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Combining chemotherapy drugs significantly improves complete remission rates and duration for acute leukemia patients. Adding immunotherapy further enhances survival outcomes in these patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia.

    Leukemia & lymphoma·2016
    Same author

    Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel. 1979.

    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis·2000
    Same author

    Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture.

    Clinical cancer research : an official journal of the American Association for Cancer Research·1999
    Same author

    Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.

    Hematologic pathology·1993
    Same author

    Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.

    Leukemia·1992
    Same author

    Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).

    Blood·1992
    Same journal

    Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

    Postgraduate medicine·2026
    Same journal

    Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

    Postgraduate medicine·2026
    Same journal

    The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

    Postgraduate medicine·2026
    Same journal

    Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

    Postgraduate medicine·2026
    Same journal

    Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

    Postgraduate medicine·2026
    Same journal

    Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

    Postgraduate medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Immunotherapy

    Background:

    • Acute leukemia treatment has historically relied on single chemotherapeutic agents.
    • Suboptimal outcomes necessitate novel therapeutic strategies.

    Purpose of the Study:

    • To evaluate the impact of combination chemotherapy versus single-agent therapy in acute leukemia.
    • To assess the added benefit of immunotherapy in conjunction with chemotherapy.

    Main Methods:

    • Retrospective analysis of patient data comparing combination chemotherapy regimens with single-agent treatments.
    • Inclusion of patients receiving immunotherapy alongside standard chemotherapy.

    Main Results:

    • Combination chemotherapy significantly increased the rate and duration of complete remission compared to single-agent therapy.

    Related Experiment Videos

  • Patients receiving immunotherapy in addition to chemotherapy demonstrated prolonged survival.

    • Conclusions:

    • Combination chemotherapy is a superior treatment strategy for acute leukemia.
    • Immunotherapy holds promise as an effective adjuvant therapy to prolong survival in acute leukemia patients.